Robert C. Meisner, MD
Medical Director, Ketamine Service
- Clinical Fellow in Psychiatry
Robert C. Meisner, MD, is the medical director of the Ketamine Service in the Psychiatric Neurotherapeutics Program at McLean Hospital and an attending psychiatrist in the Acute Psychiatric Service at Massachusetts General Hospital. He graduated from Princeton Summa cum laude and attended Harvard Medical School. His academic interests included graduate study in cultural anthropology under the American Anthropologist Arthur Kleinman, with early clinical training in internal medicine and anesthesia, critical care, and pain.
Dr. Meisner has written and lectured on a wide range of topics, including Ebola and the psychiatric consequences of quarantine, depression and existential distress in palliative care and HIV vaccine preparedness in Uganda, and the safe translation of ketamine and esketamine research into evidence-based clinical practice. He has previously served on the Administrative Board of Harvard College, as acting residential dean at Harvard College, Currier House, and on the faculty of Arts and Sciences, Harvard University.
Education & Training
- 2000 AB, Princeton University
- 2008 MD, Harvard Medical School
- 2008-2009 Residency in Internal Medicine, Beth Israel Deaconess Medical Center
- 2009-2010 Residency in Anesthesia, Critical Care, and Pain, Brigham and Women’s Hospital
- 2010-2014 Residency in Adult Psychiatry, The George Washington University Medical Center
- 2014-2016 Child and Adolescent Psychiatry Fellowship, MGH/McLean Child and Adolescent Psychiatry Training Program
- 2013 Medical License, Board of Registration in Medicine, Commonwealth of Massachusetts